The current financial score of Biote Corp is 6.73. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 43.33M, representing a year-over-year decrease of 9.64%, while its net profit experienced a year-over-year decrease of 95.03%.
The current valuation score of Biote Corp is 9.23. Its current P/E ratio is 2.12, which is 9668.11% below the recent high of 206.76 and 2324.05% above the recent low of -47.08.
The current earnings forecast score of Biote Corp is 8.00. The average price target is 2.28, with a high of 4.00 and a low of 1.50.
The current price momentum score of Biote Corp is 4.23. Currently, the stock price is trading between the resistance level at 1.21 and the support level at 0.95, making it suitable for range-bound swing trading.
The current institutional shareholding score of Biote Corp is 5.00. The latest institutional shareholding proportion is 64.13%, representing a quarter-over-quarter decrease of 13.23%.
The current risk assessment score of Biote Corp is 2.48. The company's beta value is 1.68. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.